Taiwan FDA registration 22bd7ad021ec80addea088e4cc9f4b94
"Neo-branched" third-generation test reagent for Miuris hepatitis B surface antigen
TW: “新科化”妙芮絲B型肝炎表面抗原第三代檢驗試劑
Taiwan·Risk Class 3·DIASORIN S.P.A. UK BRANCH·Registered Jul 19, 2012 – Aug 06, 2022CancelledRegistration details
- Analysis ID
- 22bd7ad021ec80addea088e4cc9f4b94
- Customs Code
- DHA00602380809
Company information
- Manufacturer
- DIASORIN S.P.A. UK BRANCH
- Manufacturer Country
- United Kingdom
- Authorized Representative
- NEW SCIENTIFIC EQUIPMENT CO., LTD.
Product details
- Intended Use
- Enzyme immunoassay legally tests human serum or plasma for hepatitis B surface antigen.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4020 Analysis of specific tests
- Import Information
- import
Dates and status
- Registration Date
- Jul 19, 2012
- Expiry Date
- Aug 06, 2022
- Cancellation Date
- Apr 12, 2024
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Neo-branched" third-generation test reagent for Miuris hepatitis B surface antigen in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 22bd7ad021ec80addea088e4cc9f4b94 and manufactured by DIASORIN S.P.A. UK BRANCH. The authorized representative in Taiwan is NEW SCIENTIFIC EQUIPMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices